Salarius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SLRX and buy or sell other stocks, ETFs, and their options commission-free!About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.
CEODavid J. Arthur
CEODavid J. Arthur
Employees16
Employees16
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2014
Founded2014
Employees16
Employees16
SLRX Key Statistics
Market cap374.86M
Market cap374.86M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume586.79K
Average volume586.79K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.985
52 Week high$0.985
52 Week low$0.1511
52 Week low$0.1511
Stock Snapshot
As of today, Salarius Pharmaceuticals(SLRX) shares are valued at $6.68. The company's market cap stands at 374.86M.
On 2026-01-14, Salarius Pharmaceuticals(SLRX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 586.79K.
Over the past 52 weeks, Salarius Pharmaceuticals(SLRX) stock has traded between a high of $0.99 and a low of $0.15.
Over the past 52 weeks, Salarius Pharmaceuticals(SLRX) stock has traded between a high of $0.99 and a low of $0.15.
People also own
Based on the portfolios of people who own SLRX. This list is generated using Robinhood data, and it’s not a recommendation.